Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanomedicine-driven molecular targeting, drug delivery, and therapeutic approaches to cancer chemoresistance
Vishwajeet M. Khot, Ashwini B. Salunkhe, Sabrina Pricl, et al.
Drug Discovery Today (2020) Vol. 26, Iss. 3, pp. 724-739
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Target based chemotherapeutic advancement of ruthenium complexes
Pragti Pragti, Bidyut Kumar Kundu, Suman Mukhopadhyay
Coordination Chemistry Reviews (2021) Vol. 448, pp. 214169-214169
Closed Access | Times Cited: 79
Recent progress in the development of nanomaterials targeting multiple cancer metabolic pathways: a review of mechanistic approaches for cancer treatment
Ling Zhang, Bing-Zhong Zhai, Yuejin Wu, et al.
Drug Delivery (2023) Vol. 30, Iss. 1, pp. 1-18
Open Access | Times Cited: 29
Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance
Guohua Li, Qiang Qu, Tingting Qi, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 54
MiRNAs Action and Impact on Mitochondria Function, Metabolic Reprogramming and Chemoresistance of Cancer Cells: A Systematic Review
Daiane Rosolen, Emanuelle Nunes-Souza, Rafael Marchi, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 693-693
Open Access | Times Cited: 18
Tumor-Homing Peptides as Crucial Component of Magnetic-Based Delivery Systems: Recent Developments and Pharmacoeconomical Perspective
Sylwia Milewska, Anna Sadowska, Natalia Stefaniuk, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6219-6219
Open Access | Times Cited: 7
Biomaterial-Based Responsive Nanomedicines for Targeting Solid Tumor Microenvironments
Konstantinos Avgoustakis, Athina Angelopoulou
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 179-179
Open Access | Times Cited: 6
Exploring metal and metal-oxide nanoparticles for nanosensing and biotic stress management in plant systems
Vijay Rani Rajpal, Yashika Dhingra, Lisha Khungar, et al.
Current Research in Biotechnology (2024) Vol. 7, pp. 100219-100219
Open Access | Times Cited: 6
Small Extracellular Vesicles and Their Involvement in Cancer Resistance: An Up-to-Date Review
Artur Słomka, Miroslaw Kornek, William C. Cho
Cells (2022) Vol. 11, Iss. 18, pp. 2913-2913
Open Access | Times Cited: 26
Effective drug and shRNA delivery for synergistic treatment of triple-negative breast cancer by sequentially targeting tumor hypoxia
Xuemeng Liu, Jiajia Sun, Jia Gu, et al.
Chemical Engineering Journal (2023) Vol. 470, pp. 144271-144271
Open Access | Times Cited: 15
Autophagy-modulating biomembrane nanostructures: A robust anticancer weapon by modulating the inner and outer cancer environment
Xinyi Zhang, Mengya Zhang, Hengqing Cui, et al.
Journal of Controlled Release (2023) Vol. 366, pp. 85-103
Closed Access | Times Cited: 14
“Challenges and toxicity assessment of inorganic nanomaterials in biomedical applications: Current status and future roadmaps”
Pranjali Mahamuni‐Badiger, Maruti J. Dhanavade
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104806-104806
Closed Access | Times Cited: 13
A polydopamine nanomedicine used in photothermal therapy for liver cancer knocks down the anti-cancer target NEDD8-E3 ligase ROC1 (RBX1)
Zhanxia Zhang, Junqian Zhang, Jianhui Tian, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 31
Phytochemical-Based Nanomedicine for Targeting Tumor Microenvironment and Inhibiting Cancer Chemoresistance: Recent Advances and Pharmacological Insights
Pratikshya Sa, Priyanka Mohapatra, Shasank S. Swain, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 11, pp. 5254-5277
Closed Access | Times Cited: 11
Synthesis of Gold Nanoparticles Using Extracts or Biomolecules Contained in Pecan Nut for Potential Applications in the Treatment of Acute Lymphoblastic Leukemia
José Guzmán Mendoza, German Hoyos Conteras, A. Castillo, et al.
IFMBE proceedings (2025), pp. 179-186
Closed Access
Combating chemoresistance: Current approaches & nanocarrier mediated targeted delivery
Siuli Shaw, Subrata K. Pore, D.-M. Liu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189261-189261
Closed Access
Recent advancements in nanoparticles for cancer treatment
Dinesh Kumar Sharma
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access
Wolf in Sheep’s Clothing: Taming Cancer’s Resistance with Human Serum Albumin?
Iga Stukan, Anna Żuk, Kamila Pukacka, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 3493-3525
Open Access
Anticancer activity of surface functionalized magnetite (Fe3O4) nanoparticles—effect of polymer coating
Nadiya N. Patel, Najiya R. Mulla, Vishwajeet M. Khot, et al.
Emergent Materials (2023) Vol. 7, Iss. 3, pp. 1071-1080
Closed Access | Times Cited: 9
Overcoming drug resistance with specific nano scales to targeted therapy: Focused on metastatic cancers
Wesam R. Kadhum, Ali A. Majeed, Raed Obaid Saleh, et al.
Pathology - Research and Practice (2024) Vol. 255, pp. 155137-155137
Closed Access | Times Cited: 3
Magnetic hydrogel (MagGel): An evolutionary pedestal for anticancer therapy
Prajkta V. Londhe, Maithili V. Londhe, Ashwini B. Salunkhe, et al.
Coordination Chemistry Reviews (2024) Vol. 522, pp. 216228-216228
Open Access | Times Cited: 3
Radiation-guided nanoparticles enhance the efficacy of PARP inhibitors in primary and metastatic BRCA1-deficient tumors via Immunotherapy
Rami Khoury, Giuseppe Longobardi, Tania Barnatan, et al.
Journal of Controlled Release (2025), pp. 113812-113812
Closed Access
Recent Progress on the Synergistic Antitumor Effect of a Borneol-Modified Nanocarrier Drug Delivery System
Jinxiu Li, Qian Xie, Rong Ma, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 23
Modulating undruggable targets to overcome cancer therapy resistance
Catherine Passirani, Anne Vessières, Giuseppe La Regina, et al.
Drug Resistance Updates (2021) Vol. 60, pp. 100788-100788
Open Access | Times Cited: 21
CAM-DR: Mechanisms, Roles and Clinical Application in Tumors
Yuejiao Huang, Yuchan Wang, Jie Tang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 20
Pharmaceutical nanoformulation strategies to spatiotemporally manipulate oxidative stress for improving cancer therapies — exemplified by polyunsaturated fatty acids and other ROS-modulating agents
Ruixue Zhang, Franky Fuh-Ching Liu, HoYin Lip, et al.
Drug Delivery and Translational Research (2022) Vol. 12, Iss. 10, pp. 2303-2334
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top